MKI67 and neoplasm: Immunohistochemistry experiments revealed that, compared to the model group, the expression of Ki-67 protein in the tumor tissues of the Nolvadex- and RRTS-treated groups was significantly reduced (P < 0.01; Figures 3C, H).